Leadership Overview
Masimo has 7 executives leading key functions including strategy, finance, and regional operations.
Driven by innovation, Masimo is dedicated to advancing patient monitoring and connectivity solutions, enhancing healthcare outcomes globally through its pioneering technologies and commitment to improving lives.
Driven by innovation, Masimo is dedicated to advancing patient monitoring and connectivity solutions, enhancing healthcare outcomes globally through its pioneering technologies and commitment to improving lives.
Leadership Roles at Masimo
Katie Szyman - Chief Executive Officer
Katie Szyman, the Chief Executive Officer at Masimo, directs the company's overarching strategy and operational execution. Overseeing all business units, Katie Szyman ensures Masimo's continued leadership in noninvasive patient monitoring technologies and medical devices. This executive role involves driving innovation across the organization, from the development of proprietary Signal Extraction Technology pulse oximetry to the expansion of hospital automation and connectivity solutions. The Chief Executive Officer's focus remains on enhancing healthcare outcomes worldwide by delivering advanced medical devices and telehealth platforms. This leadership position is critical for maintaining Masimo's market position and fostering growth in both hospital and home healthcare settings. The Chief Executive Officer's strategic vision guides the company's commitment to improving patient care through cutting-edge technology.

Tetsuro Maniwa - President & Chief Executive Officer (Japan, China, Hong Kong, Taiwan, & South Korea)
Tetsuro Maniwa, the President & Chief Executive Officer (Japan, China, Hong Kong, Taiwan, & South Korea) at Masimo, spearheads the company's strategic initiatives across key Asian markets. Overseeing operations and business development in these regions, Tetsuro Maniwa drives the adoption of Masimo's advanced patient monitoring technologies and medical devices. This executive role focuses on expanding market presence for Signal Extraction Technology pulse oximetry and hospital automation solutions. The President & Chief Executive Officer's leadership ensures alignment with Masimo's global mission to improve patient care through innovation. By managing regional sales, marketing, and distribution networks, this position is crucial for Masimo's growth in these vital territories. The focus remains on delivering cutting-edge healthcare solutions and enhancing patient outcomes throughout Japan, China, Hong Kong, Taiwan, and South Korea.

Michael Young - Executive VP & Chief Financial Officer
Michael Young, the Executive VP & Chief Financial Officer at Masimo, manages the company's financial operations and fiscal strategy. Overseeing all financial planning, reporting, and capital allocation, Michael Young ensures Masimo's financial health and sustainable growth. This executive role involves managing investor relations, optimizing financial performance, and supporting strategic investments in research and development for innovative patient monitoring technologies. The Chief Financial Officer's responsibilities extend to ensuring compliance with financial regulations and driving efficiency across all departments. By providing critical financial insights, the Chief Financial Officer supports the company's mission to deliver advanced medical devices and telehealth platforms globally. This leadership function is vital for Masimo's expansion in hospital and home healthcare markets, underpinning the company's commitment to technological advancement and improved patient outcomes.

Matthew Anacone - President, Sales & OEM(Americas & Worldwide)
Matthew Anacone, the President, Sales & OEM(Americas & Worldwide) at Masimo, directs global sales strategies and original equipment manufacturer (OEM) partnerships. Overseeing revenue generation and strategic alliances across the Americas and worldwide, Matthew Anacone drives the commercial success of Masimo's innovative patient monitoring technologies. This executive role involves expanding the reach of proprietary Signal Extraction Technology pulse oximetry and other medical devices to a broad customer base. The President, Sales & OEM's leadership is essential for securing new business opportunities and strengthening existing relationships within the healthcare industry. By focusing on market penetration and OEM collaborations, this position directly supports Masimo's mission to enhance patient care and improve healthcare outcomes globally. The strategic objective is to maximize market share and foster widespread adoption of Masimo's advanced solutions.
Mustafa Marie - Regional President, Vise Levant Africa (Turkey)
Mustafa Marie, the Regional President, Vise Levant Africa (Turkey) at Masimo, leads the company's operations and strategic growth within this critical geographic area. Overseeing market development and sales initiatives across Turkey, the Levant, and Africa, Mustafa Marie ensures the effective deployment of Masimo's advanced patient monitoring technologies and medical devices. This executive role focuses on expanding the company's footprint and driving adoption of innovative solutions like Signal Extraction Technology pulse oximetry. The Regional President's leadership is key to navigating diverse market dynamics and establishing strong partnerships within the healthcare sector. By championing Masimo's commitment to improving patient care, this position plays a vital role in enhancing healthcare outcomes throughout the region. The strategic imperative is to deliver cutting-edge medical technology and support the evolving needs of healthcare providers.
Richard Fishel - President, Worldwide OEM Business & Strategic Business Development
Richard Fishel, the President, Worldwide OEM Business & Strategic Business Development at Masimo, drives the company's global OEM partnerships and identifies new strategic growth avenues. Overseeing the expansion of Masimo's innovative patient monitoring technologies into OEM channels worldwide, Richard Fishel cultivates critical relationships with device manufacturers. This executive role is pivotal in integrating Masimo's proprietary Signal Extraction Technology pulse oximetry and other medical devices into a wider array of healthcare products. The President, Worldwide OEM Business & Strategic Business Development's focus is on forging alliances that enhance Masimo's market reach and contribute to improved patient outcomes. By exploring new business opportunities and strengthening strategic collaborations, this position is fundamental to Masimo's ongoing mission to advance healthcare globally. The objective is to maximize the impact of Masimo's technology through strategic partnerships.
Fahad Alanazi - President (Middle East, Turkey & Africa)
Fahad Alanazi, the President (Middle East, Turkey & Africa) at Masimo, directs the company's strategic expansion and operational oversight across these key international markets. Overseeing all business activities and market development initiatives, Fahad Alanazi ensures the widespread adoption of Masimo's advanced patient monitoring technologies and medical devices. This executive role is critical for driving growth and enhancing healthcare outcomes through innovative solutions like Signal Extraction Technology pulse oximetry. The President's leadership focuses on building strong regional presence and fostering partnerships within the healthcare ecosystem. By championing Masimo's commitment to improving lives through technology, this position plays a significant role in delivering cutting-edge medical solutions across the Middle East, Turkey, and Africa. The strategic goal is to maximize market penetration and support healthcare providers with advanced monitoring capabilities.
Explore Leadership Teams in Manufacturing
BD is widely perceived as a global medical technology company that develops and manufactures medical devices, diagnostic systems, laboratory equipment, and healthcare solutions. The company supports hospitals, laboratories, and healthcare providers through innovations in patient safety, drug delivery, diagnostics, and biosciences.
Company Leadership
FA
KW

ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



Highridge Medical is a company that operates in the Medical Devices industry. It employs 1-5 people and has $0M-$1M of revenue. The company is headquartered in Langley, British Columbia, Canada.
Company Leadership
SB
JB

US Med-Equip, headquartered in Houston, Texas, is a medical equipment and supplies company that specializes in providing durable medical equipment (DME) and related healthcare products. The company serves healthcare facilities, medical professionals, and patients by offering a comprehensive range of medical devices and equipment solutions. US Med-Equip focuses on delivering quality medical supplies that support patient care and clinical operations across various healthcare settings. Their product offerings include essential medical equipment designed to meet the needs of hospitals, clinics, long-term care facilities, and home healthcare environments. The company operates as a reliable supplier in the medical equipment distribution sector, ensuring healthcare providers have access to the necessary tools and devices required for effective patient treatment and care delivery.
Company Leadership
CR
AV